enow.com Web Search

Search results

1. ^CLL - CBOE S&P 500 95 110 COLLAR

   Yahoo Finance

   • News
   •  Charts
   •  Conversations

   • Range :
   • 1d
   • 5d
   • 6m
   • 1y
   • Max

   1,558.76+11.85 (+0.77%)

   at Fri, May 31, 2024, 4:15PM EDT - U.S. markets closed

   Delayed Quote

   • Open 1,549.67
   • High 1,559.50
   • Low 1,534.65
   • Prev. Close 1,546.91

   • 52 Wk. High 1,559.50
   • 52 Wk. Low 1,534.65
   • P/E N/A
   • Mkt. Cap N/A

   • Chicago Options
   • •Price in USD

2. Results from the WOW.Com Content Network

3. Chronic lymphocytic leukemia - Wikipedia

   en.wikipedia.org/wiki/Chronic_lymphocytic_leukemia

   Treatment. CLL treatment focuses on controlling the disease and its symptoms rather than on an outright cure. In those without or only minimal symptoms watchful waiting is generally appropriate. CLL is treated by chemotherapy, radiation therapy, biological therapy, or bone marrow transplantation.

4. Richter's transformation - Wikipedia

   en.wikipedia.org/wiki/Richter's_transformation

   Richter's transformation (RT), also known as Richter's syndrome, is the conversion of chronic lymphocytic leukemia (CLL) or its variant, small lymphocytic lymphoma (SLL), into a new and more aggressively malignant disease.

5. Ofatumumab - Wikipedia

   en.wikipedia.org/wiki/Ofatumumab

   Ofatumumab (Arzerra 100 mg or 1000 mg concentrate for solution for infusion) is indicated for the treatment of untreated, relapsed, or refractory chronic lymphocytic leukemia (CLL). [8] [20] [6] [21] The recommended doses for treatment of CLL are higher than MS, with 1000 or 2000 mg infusions administered monthly depending on if the CLL is ...

6. Chlorambucil - Wikipedia

   en.wikipedia.org/wiki/Chlorambucil

   Chlorambucil, sold under the brand name Leukeran among others, is a chemotherapy medication used to treat chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and non-Hodgkin lymphoma. For CLL it is a preferred treatment. It is given by mouth. Common side effects include bone marrow suppression.

7. Response evaluation criteria in solid tumors - Wikipedia

   en.wikipedia.org/wiki/Response_Evaluation...

   Response evaluation criteria in solid tumors (RECIST) is a set of published rules that define when tumors in cancer patients improve ("respond"), stay the same ("stabilize"), or worsen ("progress") during treatment.

8. Alemtuzumab - Wikipedia

   en.wikipedia.org/wiki/Alemtuzumab

   Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia and multiple sclerosis. In chronic lymphocytic leukemia, it has been used as both a first line and second line treatment. It is given by injection into a vein.